Related Experiment Video
Updated: Sep 13, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Determinants of initiating cancer treatment among breast cancer survivors: a descriptive qualitative study
Walaa R Almallah1,2, Tamilyn Bakas3, Elizabeth Shaughnessy4
1PhD Candidate, College of Nursing, University of Cincinnati, Cincinnati, OH, USA.
Background:
The timing of cancer treatment initiation is a critical factor impacting cancer metastasis, recurrence, morbidity, mortality and overall survival rates. Based on the Health Belief Model, health beliefs and cues to action may influence treatment initiation in women with breast cancer.
Aim:
This study aimed to explore health beliefs and cues to initiate treatment among breast cancer survivors.
Methods:
Breast cancer survivors undergoing cancer treatment were recruited for a descriptive qualitative study. Semi-structured interviews were conducted. A content analysis was undertaken.
Results:
Breast cancer survivors (N = 25) had a mean age of 51.6 years, were primarily Caucasian (n = 17; 68%), and on average 31 months post-diagnosis. Health belief subcategories emerged: (1) personal, social and cancer-related benefits; (2) personal, social, physical/health, financial/health insurance-related, treatment-related, facility-related and community-related barriers; (3) perceived threats involving death, cancer spreading, recurrence and more aggressive treatments and (4) self-efficacy influenced by a support system, trusted healthcare professionals, and life responsibilities. The cues to initiate treatment were social, mental, individual, and healthcare-related.
Conclusion:
Women's health beliefs and cues to initiate treatment could be assessed by nurses and other disciplines working collaboratively to minimise the challenges that may cause delayed treatment initiation. Advocating for policies is recommended.
Related Concept Videos
Cancer Survival Analysis
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Prevention
Some...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

